Mark Angelo MD MHA, FACP
Hospice & Palliative Medicine, Hospital Medicine/Hospitalist
Chief Medical Officer for Population Health, Penn Medicine; University of Pennsylvania Health System
Join to View Full Profile
1865 Route 70 ESecond FloorCherry Hill, NJ 08003
Phone+1 215-316-5151
Fax+1 215-503-3152
Dr. Angelo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mark Angelo is an internist and palliative medicine physician in Philadelphia, PA. Dr. Angelo is the inaugural CMO for Population Health at Penn Medicine of the University of Pennsylvania Health System. He is also a Clinical Professor of Medicine within the Pearlman School of Medicine.
Education & Training
Lewis Katz School of Medicine at Temple UniversityClass of 1998
Certifications & Licensure
NJ State Medical License 2003 - 2027
PA State Medical License 2000 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hospice and Palliative Medicine
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
Publications & Presentations
PubMed
- 1 citationsCost Reduction and Utilization Patterns in a Medicare Accountable Care Organization Using Home-Based Palliative Care Services.Mark Angelo, Abigail Souder, Angela Poole, Terre Mirsch, Elizabeth Souder
Population Health Management. 2024-02-01 - Future Trends to Watch for Value-Based Care.Mark Angelo, Joel Port
Population Health Management. 2023-08-01 - 2 citationsAducanumab Fails to Produce Efficacy Results Yet Obtains US Food and Drug Administration ApprovalMark Angelo, Lawrence Ward
Population Health Management. 2021-09-13
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
